SLC12A5 and Alzheimer disease: Causality has been probed pharmacologically: enhancing KCC2 function (e.g., CLP290) restored spatial memory and social behavior in AD models, whereas KCC2 inhibition (e.g., VU0463271) impaired performance, linking defective Cl− extrusion to cognitive decline in these settings [9].